CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 4 Planned sale Director sold 10,000 shares at an average $66.65 ($666,465)
- 4 Shares withheld for taxes Chief Executive Officer gave up 32,855 shares (to pay taxes)
- 4 Planned sale President and CFO sold 16,934 shares at an average $66.46 ($1,125,404)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 4,781 shares (to pay taxes)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 25,484 shares at $66.07 ($1,683,728)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $62.29 ($4,983,111)
- 4 Open-market sale Director sold 61,031 shares at $63.72 ($3,888,999)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 198,359 shares at an average $66.58 ($13,206,528)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,641 shares at $65.00 ($106,665)
- 10-Q Report Quarterly Report
- 8-K Event Other events
Page 7 of 42 · 834 filings